CSI Market
Sign In | Register

Orgenesis Inc (ORGS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ORGS Annual Cash Flow →
Cash flow data covering Orgenesis Inc–Dec 31 2023 offers a view into how Dec 31 2024's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-49.01
Depreciation & amortization2.09
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived18.34
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.03
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation3.19
Income (Loss) from Equity Method Investments0.01
Gains (Losses) on Extinguishment of Debt5.42
Write Off Of Website Development Costs-
Derivative Gain Loss On Derivative Net-
Interest Expense Short Term Borrowings-
Stockbased Compensation Related To Options Granted To Service Providers Including Receipts On Account-
Defined Benefit Plan Benefit Obligation Period Increase Decrease-
Stock Based Compensation Expense To First Choice-
Capital Loss Gain Net-
Increase Decrease In Exchange Differences On Inter Company Balances-
Increase Decrease In Contract With Customer Liability-
Share Based Compensation-
Share Based Compensation One-
Increase Decrease In Effect Of Exchange Differences On Intercompany Balances1.67
Credit Loss On Convertible Loan Receivable-
Convertible Loan Induced Conversion Expenses4.30
Increase Decrease In Related Parties Net0.13
Deconsolidation Gain Or Loss Amount0.07
Income taxes0.00
Gain (Loss) on Disposition of Stock in Subsidiary0.00
Accounts Receivable1.43
Increase (Decrease) in Accounts Payable-1.28
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.82
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets2.26
Other Working Capital0.04
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.05
Discontinued operations0.00
Net Cash flow from Operating Activities-17.08
Investing Activities
Capital Expenditures-0.26
Sale of Capital Items0.00
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Acquisition Of Atvio Net Of Cash Acquired-
Payments For Investments-
Payments Of Investment In Longterm Deposits-
Payments Of Investment Deposits-
Impact To Cash Resulting From Deconsolidation-0.01
Repayment Of Loan Granted-
Increase (Decrease) in Restricted Cash and Investments0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Long-term Investments, Total0.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.14
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.37
Financing Activities
Short-term debt Net6.06
Other borrowing transactions0.00
Long-term debt - borrowings0.62
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.56
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Exercise Of Warrants Into Shares And Warrants-
Proceeds From Repayments Of Redeemable Non Controlling Interest-
Proceeds From Receipts On Account Of Shares To Be Allotted-
Proceeds From Grants Received-
Grants Received-
Repayment Of Treasury Stock-
Proceeds From Receipts On Account Of Shares And Warrants To Be Allotted-
Receipt From Germ Free-
Proceeds From Transaction With Redeemable Noncontrolling Interest Th at Do Not Acquire Control Of Subsidiary-
Receipt From Purchaser6.72
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities15.96
Effect of exchange rate on cash flow-0.04
Discontinued operations0.00
Free Cash Flow-17.34
Total Cash Flow-0.75
4 historic quarters locked

Sign in to unlock the full Orgenesis Inc cash flow history.

Sign In Create Free Account

About Orgenesis Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 13, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-044972

Figures are derived from filed reports and may be restated. Historical data is subject to revision.